Home > News

News

Continuing Contraception Care After Trump’s Orders

In light of recent actions over the last two weeks with our new administration, I wanted to provide updates and guidance to my pharmacist peers regarding reproductive health care. On Friday afternoon, some CDC websites went down as content is being reviewed for compliance with President Trump’s executive orders. Pharmacists, along with other health professionals,…

Over-the-Counter Birth Control Pills: FDA Considering HRA Pharma’s Opill

Why Over-the-Counter Birth Control? Oral contraceptives have been around since 1960, and their risks and safety profiles have been well-studied throughout the years. According to the Guttmacher Institute, unplanned pregnancies account for 45% of all pregnancies in the US. Furthermore, nearly one-third of individuals who have tried to obtain a prescription for hormonal contraception report…

Nextstellis®: A new drug update 

  A new combined oral contraceptive was approved by the FDA (Nextstellis®) in April 2021.1 Nextstellis contains estetrol, an estrogen that can be manufactured from plants and that was originally derived naturally during pregnancy from the fetus liver, and drospirenone, a progestin found in other currently available contraceptives. Drospirenone has antiandrogenic and anti-mineralocorticoid activity.2 Estetrol differs…

Updated Report on State Policy Efforts to Expand Access to Contraception in Pharmacies

Download free 22-page report describing the current landscape of direct access to contraception in pharmacies, state policy approaches and experiences, as well as implementation.

Levonorgestrel Intrauterine Device for Emergency Contraception

A new research study evaluates levonorgestrel IUD for emergency contraception

Webinar Introduces Pharmacists to New Hormonal Contraceptives

New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.

Webinar Equips Pharmacists to Provide Contraception Care During COVID-19

New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.

Reducing Maternal Mortality in the United States through Collaboration

New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.

New Webinar Prepares Pharmacists to Provide Reproductive Health Services and Referrals

New training program by Birth Control Pharmacist and Provide includes pharmacy best practices to combat stigma and communication guides and online resources to help connect patients with local resources.

Meet Phexxi – A New Non-Hormonal Contraceptive Gel

About the Product Lactic acid, citric acid, and potassium bitartrate (Phexxi, Evofem Biosciences) is a prescription combination, non-hormonal contraceptive gel approved by the FDA in May 2020. The vaginal gel was found to be 86.3% effective with typical use when inserted up to 1 hour before vaginal intercourse.1 The gel acts as a contraceptive by…